Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Travere Therapeutics Inc’s stock clocked out at $6.75, up 3.05% from its previous closing price of $6.55. In other words, the price has increased by $3.05 from its previous closing price. On the day, 1.94 million shares were traded. TVTX stock price reached its highest trading level at $7.69 during the session, while it also had its lowest trading level at $6.74.
Ratios:
To gain a deeper understanding of TVTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 2.78. In the meantime, Its Debt-to-Equity ratio is 5.45 whereas as Long-Term Debt/Eq ratio is at 5.39.
On December 05, 2023, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7 to $10.
On November 20, 2023, Citigroup started tracking the stock assigning a Neutral rating and target price of $7.Citigroup initiated its Neutral rating on November 20, 2023, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 11 ’24 when Cline Christopher R. sold 54 shares for $6.74 per share. The transaction valued at 364 led to the insider holds 70,849 shares of the business.
Dube Eric M sold 19,122 shares of TVTX for $166,435 on Feb 01 ’24. The CHIEF EXECUTIVE OFFICER now owns 350,600 shares after completing the transaction at $8.70 per share. On Feb 01 ’24, another insider, REED ELIZABETH E, who serves as the SVP, GC & CORPORATE SECRETARY of the company, sold 4,764 shares for $8.71 each. As a result, the insider received 41,495 and left with 76,270 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 513734400 and an Enterprise Value of 476842880. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.80 while its Price-to-Book (P/B) ratio in mrq is 6.94. Its current Enterprise Value per Revenue stands at 3.062 whereas that against EBITDA is -1.266.
Stock Price History:
Over the past 52 weeks, TVTX has reached a high of $19.54, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is -4.17%, while the 200-Day Moving Average is calculated to be -25.99%.
Shares Statistics:
It appears that TVTX traded 1.24M shares on average per day over the past three months and 1546900 shares per day over the past ten days. A total of 75.37M shares are outstanding, with a floating share count of 75.03M. Insiders hold about 1.41% of the company’s shares, while institutions hold 116.10% stake in the company. Shares short for TVTX as of 1713139200 were 11802198 with a Short Ratio of 9.51, compared to 1710460800 on 10071652. Therefore, it implies a Short% of Shares Outstanding of 11802198 and a Short% of Float of 17.45.
